Parkinson Disease
Medicine & Life Sciences
100%
Neuroprotective Agents
Medicine & Life Sciences
70%
Stroke
Medicine & Life Sciences
66%
Transplantation
Medicine & Life Sciences
55%
Glial Cell Line-Derived Neurotrophic Factor
Medicine & Life Sciences
48%
Oxidopamine
Medicine & Life Sciences
47%
Cell- and Tissue-Based Therapy
Medicine & Life Sciences
42%
Neurogenesis
Medicine & Life Sciences
41%
Matsuda, Y. ,
Otani, Y. ,
Yasuhara, T. ,
Ando, M. ,
Higaki, T. ,
Makino, T. ,
Matsumoto, H. ,
Oyama, T. ,
Nishimori, H. &
Date, I. ,
2月 1 2023 ,
In: Acta medica Okayama. 77 ,
1 ,
p. 85-90 6 p. 研究成果 › 査読
Retinoblastoma
100%
Skull Base
92%
Osteosarcoma
88%
Radiation
63%
Middle Cranial Fossa
60%
Hosomoto, K. ,
Sasaki, T. ,
Yasuhara, T. ,
Kameda, M. ,
Sasada, S. ,
Kin, I. ,
Kuwahara, K. ,
Kawauchi, S. ,
Okazaki, Y. ,
Yabuno, S. ,
Sugahara, C. ,
Kawai, K. ,
Nagase, T. ,
Tanimoto, S. ,
Borlongan, C. V. &
Date, I. ,
3月 1 2023 ,
In: Brain Stimulation. 16 ,
2 ,
p. 594-603 10 p. 研究成果 › 査読
Afferent Pathways
100%
Vagus Nerve Stimulation
97%
Parkinson Disease
61%
Vagotomy
18%
Vagus Nerve
12%
Yabuno, S. ,
Yasuhara, T. ,
Nagase, T. ,
Kawauchi, S. ,
Sugahara, C. ,
Okazaki, Y. ,
Hosomoto, K. ,
Sasada, S. ,
Sasaki, T. ,
Tajiri, N. ,
Borlongan, C. V. &
Date, I. ,
12月 2023 ,
In: Stem Cell Research and Therapy. 14 ,
1 , 123.
研究成果 › 査読
Intracerebral
100%
School Dentistry
92%
Stem Cell Research
82%
Running
64%
Cell- and Tissue-Based Therapy
58%
Yabuno, S. ,
Yasuhara, T. ,
Nagase, T. ,
Kawauchi, S. ,
Sugahara, C. ,
Okazaki, Y. ,
Hosomoto, K. ,
Sasada, S. ,
Sasaki, T. ,
Tajiri, N. ,
Borlongan, C. V. &
Date, I. ,
12月 2023 ,
In: Stem Cell Research and Therapy. 14 ,
1 , 10.
研究成果 › 査読
Intracerebral
100%
Running
64%
Mesenchymal Stem Cells
55%
Therapeutic Uses
50%
Middle Cerebral Artery Infarction
48%
Hosomoto, K. ,
Sasaki, T. ,
Kawai, K. ,
Okazaki, Y. ,
Hyodo, Y. ,
Shibata, T. ,
Sasada, S. ,
Yasuhara, T. ,
Kobayashi, K. ,
Yanai, H. &
Date, I. ,
6月 1 2022 ,
In: Acta medica Okayama. 76 ,
3 ,
p. 323-328 6 p. 研究成果 › 査読
Focal cortical dysplasia of Taylor
100%
Intracranial
90%
Tuberous Sclerosis
69%
Refractory
58%
Malformations of Cortical Development
38%